Technology News and Research

RSS

$4.5 million contract to develop heart assist devices for infants

The University of Pittsburgh's McGowan Institute for Regenerative Medicine has been awarded a five-year $4.5 million contract from the National Heart, Lung, and Blood Institute to develop a heart assist device for infants.

28 Apr 2004

AGT Biosciences Limited and ChemGenex Therapeutics today announced merger agreement

AGT Biosciences Limited of Melbourne, Australia and privately held ChemGenex Therapeutics, Inc. of Menlo Park, California, today announced that they have signed a merger agreement. The cross-border merger creates a new, genomics-driven pharmaceutical company with leading edge capabilities for drug discovery and development, as well as two drug candidates in Phase II human trials for cancer.

28 Apr 2004

BioTime awarded a research grant for blood plasma volume expander

BioTime, Inc. has announced that it has been awarded a research grant by the National Heart, Lung, and Blood Institute division of the National Institutes of Health (NIH) for use in the development of its HetaCool® blood plasma volume expander following peer review.

27 Apr 2004

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Helix BioMedix today announced that it has completed a 12-week consumer product test comparing the company's anti-wrinkle peptide, HB168 with Renova(R), a currently marketed FDA approved product.

27 Apr 2004

Biological bandages are being successfully used to treat patients with severe burns

Doctors have been impressed with the rapid recovery rates instigated by the ‘tailor-made ’ discs, which have been devised by a research team at the Sheffield company, CellTran, with financial support from the Wellcome Trust biomedical research charity and the White Rose Technology Seedcorn Fund. They will be officially launched at the British Burn Association’s annual meeting in Manchester tomorrow (28th).

27 Apr 2004

UK moves towards controversial 'biometric' passports

In a move which is surely to cause controversy Home Secretary David Blunkett has published a draft Bill on a national ID card scheme.

26 Apr 2004

Medical students are seeking to uncover a silent killer, glaucoma

Like private eyes, a group of medical students at the College of Medicine are seeking to uncover a silent killer attacking unsuspecting citizens of Tucson: glaucoma.

26 Apr 2004

New ion exchange resin will help people with thyroid gland problems

Rohm and Haas Company has introduced Amberlite® PWA2 ion exchange resin, the first resin specifically designed for the selective removal of perchlorate from drinking water.

26 Apr 2004

FDA fast tracks human African sleeping sickness (Trypanosomiasis) drug

Immtech International, Inc. has announced that the U.S. Food and Drug Administration has granted Immtech's first oral drug, DB289, fast track drug development designation for use to treat human African sleeping sickness (Trypanosomiasis).

26 Apr 2004

Clinical trial of enzyme replacement therapy for the treatment of Gaucher disease

Transkaryotic Therapies, Inc. today announced that it has initiated a clinical trial to evaluate the safety and clinical activity of GA-GCB, its enzyme replacement therapy for the treatment of Gaucher disease.

26 Apr 2004

SARS antibody sent to China

Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.

26 Apr 2004

New analytical approach that combines genetic and clinical data to give individualized prognosis of cancer recurrence

Researchers at Duke University have developed a new analytical approach that combines genetic and clinical data to give cancer patients an individualized prognosis of their cancer recurrence. The information could prove critical in deciding how aggressively to treat the disease following surgery.

26 Apr 2004

Scientists studying the adhesive properties of the neural cell adhesion molecule have found that two opposing models of cell adhesion are both correct

Scientists studying the adhesive properties of the neural cell adhesion molecule (NCAM) -- a protein that helps bind the nervous system together -- have found that two opposing models of cell adhesion are both correct.

26 Apr 2004

St. Francis uses latest technology to comfort surgery patients

The old cotton patient gowns and warmed cotton blankets are history in St. Francis’ Procedural Services Department. Surgery patients can now control their warmth while wearing the Bair Paws patient adjustable warming system. The Bair Paws system combines forced-air warming and patient gowning in one step.

26 Apr 2004

Sleepwalking into our technological future

There has been a lack of public debate and there is a very real danger that we are ‘sleepwalking’ into our technological future

24 Apr 2004

Improving eye care with telemedicine

Computer scientists at the National Institute of Standards and Technology (NIST) have teamed up with a group of medical professionals to advance the use of telemedicine.

23 Apr 2004

Mass spectrometry offers promising diagnostic test for sleeping sickness

Around half a million people a year in sub-Saharan Africa are affected by sleeping sickness (human African trypanosomiasis). The disease is fatal in humans if not treated with chemotherapy; however, adverse effects of drug treatment and an increase in drug resistance underline the importance of establishing an accurate diagnostic test for the disease.

22 Apr 2004

WHO renews call for effective malaria treatment

More than 600 million people, most of them children living in sub-Saharan Africa, face the daily threat of death from malaria because new, effective treatments are not available where they live. Existing, cheaper medicines, which have been used for many years, are no longer effective in most places because the malaria parasite has developed resistance to them.

22 Apr 2004

SkyePharma delivery technologies for respiratory drugs to feature at two international conferences

SkyePharma PLC has announced that its proprietary delivery technologies for respiratory drugs will be presented later this month at two international conferences, one in the UK and one in America.

22 Apr 2004

Schering-Plough submits Japanese application for hepatitis C drug

Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.

22 Apr 2004